31. Predictive assays of tumor response to chemo and radiotherapyMaja Čemažar, 1999, pregledni znanstveni članek Povzetek: Predstavljeni so testi za napovedovanje izida zdravljenja tumorjev po kemo- inradioterapiji in poškodb normalnih tkiv po radioterapiji. Pregled je osredotočen na tiste teste, pri katerih je treba celice gojiti v pogojih in vitro. Poleg tega članek obravnava tudi korelacijo med napovednimi testi in izidom zdravljenja različnih vrst raka ter poškodbami normalnih tkiv.
Objavljeno v DiRROS: 22.01.2024; Ogledov: 207; Prenosov: 59
 Celotno besedilo (692,06 KB) |
32. |
33. Vinblastine increases antitumor effectiveness of bleomycinMaja Čemažar, Marija Auersperg, Gregor Serša, 1997, izvirni znanstveni članek Povzetek: In our previous vinblastine (VELBE) was shown to increase the plasma membrane fluidity. This effect of VELBE might be expolited for better transport of drugs through the plasma membrane. Bleomycin (BLM) is a highly cytotoxic drug when present inside the cells but has a hampered transport through the plasma membrane. The aim of the present study was to determine whether pretreatment with VELBE can increase the effect of BLM on intraperitoneal SA-1 tumors in mice. BLM and VELBE were used as single agents or in various combinations, i.e. VELBE and BLM injected simultanously, BLM injected 24 h before VELBE or VELBE injected 24 h before BLM. Mice survival was the end-point used for determining the effect of this combined treatments. VELBE and BLM as a single treatment significantly prolonged median survival time of study animals compared to controls. Furthermore, when VELBE and BLM were combined, all threetested combinations were more effective than VELBE or BLM as single treatments. The effect on animal survival was equal when VELBE was given 24 h after or simultanously with BLM. The longest survival, however was obtained when VELBE was injected 24 h before BLM. From these results we can conclude that the underlying mechanisms for more than additive effect of VELBE and BLM when VELBE was given 24 h before BLM could be attributed to an increased membrane fluidity, possibly in combination with a cell kinetic effect.
Objavljeno v DiRROS: 18.01.2024; Ogledov: 187; Prenosov: 43
Celotno besedilo (1,28 MB) |
34. Study of blood perfusion with patent blue staining method in LPB fibrosarcoma tumors in immuno-competent and immuno-deficient mice after electrotherapy by direct currentTomaž Jarm, Dong Jian An, Jean Belehradek, Lluis M. Mir, Gregor Serša, Maja Čemažar, Tadej Kotnik, Jani Pušenjak, Damijan Miklavčič, 1997, izvirni znanstveni članek Objavljeno v DiRROS: 16.01.2024; Ogledov: 201; Prenosov: 45
Celotno besedilo (344,22 KB) |
35. Electrochemotherapy with bleomycin : The first clinical experience in malignant melanoma patientsZvonimir Rudolf, Borut Štabuc, Maja Čemažar, Damijan Miklavčič, Lojze Vodovnik, Gregor Serša, 1995, izvirni znanstveni članek Ključne besede: melanoma therapy, bleomycin, electric stimulation therapy
Objavljeno v DiRROS: 15.01.2024; Ogledov: 242; Prenosov: 54
Celotno besedilo (418,42 KB) |
36. Improved therapeutic effect of electrochemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization on EAT tumor model in miceMaja Čemažar, Damijan Miklavčič, Lojze Vodovnik, Tomaž Jarm, Zvonimir Rudolf, Borut Štabuc, Tanja Čufer, Gregor Serša, 1995, izvirni znanstveni članek Ključne besede: neoplasmas, experimental therapy, cisplatin, electric stimulation therapy, cell membrane permeability
Objavljeno v DiRROS: 15.01.2024; Ogledov: 194; Prenosov: 56
Celotno besedilo (393,12 KB) |
37. |
38. Elektrokemoterapija pri lokalnem zdravljenju napredovalega melanomaGregor Serša, Zvonimir Rudolf, Marija Snežna Paulin-Košir, Janja Ocvirk, Maja Čemažar, Simona Kranjc Brezar, Breda Slekovec Kolar, Marko Snoj, 2007, objavljeni znanstveni prispevek na konferenci Objavljeno v DiRROS: 06.12.2023; Ogledov: 272; Prenosov: 64
Celotno besedilo (779,60 KB) |
39. Elektrokemoterapija malignega melanomaGregor Serša, Borut Štabuc, Tanja Čufer, Boris Jančar, Damijan Miklavčič, Maja Čemažar, Zvonimir Rudolf, 1999, objavljeni znanstveni prispevek na konferenci Ključne besede: melanom, zdravljenje, bleomicin, cisplatin, električna stimulacija, elektrokemoterapija, elektroporacija, melanoma therapy, bleomycin, cisplatin, electric stimulation therapy, electrochemotherapy, electroporation
Objavljeno v DiRROS: 27.11.2023; Ogledov: 214; Prenosov: 72
Celotno besedilo (617,96 KB) |
40. Radiosenzibilizacija tumorjev z elektroprenosom plazmida za dve antiangiogeni tarčiMonika Savarin, Katarina Žnidar, Gregor Serša, Tilen Komel, Maja Čemažar, Urška Kamenšek, 2023, objavljeni povzetek znanstvenega prispevka na konferenci Ključne besede: miši, elektroprenos genov, gensko zdravljenje
Objavljeno v DiRROS: 19.06.2023; Ogledov: 383; Prenosov: 146
Celotno besedilo (310,08 KB)
Gradivo ima več datotek! Več... |
